Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy: A Prospective Randomized Multicenter Study

NCT02769169 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT02769169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02769169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy: A Prospective Randomized Multicenter Study
Lead sponsor
Sun Yat-sen University
Phase
Phase 2/3
Overall status
Terminated
Start date
August 1, 2018
Completion date
December 15, 2018
Enrollment
5 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy